These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16791021)

  • 1. The legacy of unhygienic plasma collection in China.
    Mastro TD; Yip R
    AIDS; 2006 Jun; 20(10):1451-2. PubMed ID: 16791021
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.
    Kleinman S; Busch MP; Korelitz JJ; Schreiber GB
    Transfus Med Rev; 1997 Jul; 11(3):155-72. PubMed ID: 9243769
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 4. Poverty and the spread of bloodborne disease in central China.
    Tucker JD; Lin CC
    J Infect Dis; 2006 Mar; 193(6):902-3. PubMed ID: 16479531
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of Hepatitis C Virus and Hepatitis B Virus Infections in Patients Infected with HIV Through Blood Donation or Transfusion in China.
    Zeng QL; Yu ZJ
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1203. PubMed ID: 26160448
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV/AIDS and hepatitis C transmission by blood transfusion: zero risk does not exist].
    Rev Infirm; 2002 Apr; (80):11. PubMed ID: 12046116
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China.
    Qian HZ; Vermund SH; Kaslow RA; Coffey CS; Chamot E; Yang Z; Qiao X; Zhang Y; Shi X; Jiang Y; Shao Y; Wang N
    AIDS; 2006 Jun; 20(10):1429-35. PubMed ID: 16791018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No need for bad blood over bad blood.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2015 May; 15(5):487. PubMed ID: 25932570
    [No Abstract]   [Full Text] [Related]  

  • 10. The risk of transfusion-transmitted infection.
    Dodd RY
    N Engl J Med; 1992 Aug; 327(6):419-21. PubMed ID: 1625717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dangerous outcomes of blood transfusion to thalassemia patients in Pakistan.
    Shah DA
    J Infect Public Health; 2015; 8(5):510-1. PubMed ID: 25731675
    [No Abstract]   [Full Text] [Related]  

  • 13. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia.
    Ben Jemia R; Gouider E
    Transfus Clin Biol; 2014 Dec; 21(6):303-8. PubMed ID: 25458983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa.
    Nagalo BM; Bisseye C; Sanou M; Kienou K; Nebié YK; Kiba A; Dahourou H; Ouattara S; Nikiema JB; Moret R; Zongo JD; Simpore J
    Trop Med Int Health; 2012 Feb; 17(2):247-53. PubMed ID: 21988100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP
    Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of transfusion transmitted infections in blood donors: an Indian experience.
    Chandra T; Kumar A; Gupta A
    Trop Doct; 2009 Jul; 39(3):152-4. PubMed ID: 19535750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood-transfusion in Vietnam].
    Nakada S
    Nihon Koshu Eisei Zasshi; 1994 Jan; 41(1):95-100. PubMed ID: 7906568
    [No Abstract]   [Full Text] [Related]  

  • 19. Residual risk of transfusion transmitted viral infections among seronegative donors: application of the incidence/window period model.
    Kleinman S
    Dev Biol (Basel); 2000; 102():61-5. PubMed ID: 10794091
    [No Abstract]   [Full Text] [Related]  

  • 20. [Procedure of Look Back (pursuant to 19 Transfusion Law). At the 62nd meeting of the Work Group Blood on June 14, 2006 the following vote (V 34) was passed].
    Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):940-57. PubMed ID: 16953363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.